Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.69 USD | -3.66% | -6.72% | +313.00% |
08/05 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
08/05 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JANUX THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.28% | -6.72% | +313.00% | +213.62% | - | 235.12Cr |
- Stock Market
- Equities
- JANX Stock
- Charts Janux Therapeutics, Inc.
- Relative Strength Chart